Note 9 - Common Stock | Note 9 Common Stock Our authorized capital stock consists of 300,000,000 shares of common stock, with a par value of $0.001 per share, and 10,000, On July 19, 2018, the Company issued 300,000 shares of restricted common stock, at $0.03 per share, to a consultant for services values at approximately $9,000. On August 21, 2018, the Company completed a sale of our restricted common shares to a private investor. The Company sold a total of 750,000 shares of restricted common stock at a price of $0.10 per share for an aggregate amount of $75,000 received by the Company. In addition, the Company issued a warrant to purchase an additional 750,000 shares of our restricted common stock at an exercise price of $0.10 per share on or before August 20, 2019. As of March 31, 2019, the warrant has not been exercised. On October 2, 2018, the Company issued 300,000 shares of restricted common stock, at $0.03 per share, to a consultant for services values at approximately $9,000. On January 2, 2019, the Company entered into a Strategic Advisory agreement with an individual. As consideration for this position, the Company granted this individual 300,000, 10-year common stock options at an exercise price of $0.08 per share. The Black-Scholes pricing model was used to estimate the fair value of the 300,000 options issued during the period, using the assumptions of a risk free interest rate of 2.7%, dividend yield of 0%, volatility of 330%, and an expected life of one year. The options have a fair value of approximately $13,000 and have not been exercised. On February 5, 2019, the Company entered into an agreement for legal services in regards to various corporate and securities law matters. In consideration of services to be performed, the Company has agreed to pay a monthly fee of $2,000 in cash and issue upon the date hereof a warrant to purchase up to 500,000 shares of our common stock, at the exercise price of $0.08 per share, on or before December 31, 2024. Effective February 5, 2019, and continuing on the first day of each subsequent calendar month thereafter, 41,667 shares of our common stock shall vest and become exercisable under this warrant (all 500,000 shares shall vest on January 1, 2020), provided that on such vesting date, our legal engagement with us has not been terminated by us. The Black-Scholes pricing model was used to estimate the fair value of the 500,000 options issued during the period, using the assumptions of a risk free interest rate of 1.1%, dividend yield of 0%, volatility of 288%, and an expected life of one year. The options have a fair value of approximately $14,000 and have not been exercised. In February 2019, the Company completed a sale of our restricted common shares to private investors. The Company sold a total of 2,300,000 shares of restricted common stock at a price of $0.10 per share for an aggregate amount of $230,000 received by the Company. In addition, the Company issued warrants to purchase an additional 2,300,000 shares of our restricted common stock at an exercise price of $0.10 per share on or before February, 2020. The warrants have not been exercised. On May 21, 2018, the Board approved the issuance of 1,300,000 common stock plan options with an exercise price of $0.08 per share. The options were granted to replace Mr. Mathers 1,000,000 options which expired on March 19, 2018. The term of the new options is 7 years and vest immediately. The Black-Scholes pricing model was used to estimate the fair value of the 1,300,000 options issued during the period, using the assumptions of a risk free interest rate of 1.1%, dividend yield of 0%, volatility of 295%, and an expected life of 7 years. We have determined these options to have an approximate fair value of approximately $91,000. These options have been expensed during the year ended March 31, 2019. At March 31, 2019, the total issued and outstanding shares were 63,216,787. Common Stock Options and Warrants A summary of the Company's stock option activity and related information for the two year period ended March 31, 2019 is as follows: Options Price Range Weighted Average Remaining Life (Years) Outstanding March 31, 2018 7,350,000 $ 0.06 0.14 5.78 Granted 2,100,000 $ 0.07 0.08 6.68 Cancelled/Expired (1,000,000) $ 0.14 - Exercised - - - Outstanding and exercisable March 31, 2019 8,450,000 0.06 0.13 6.06 A summary of the Company's stock warrant activity and related information for the two year period ended March 31, 2019 is as follows: Warrants Price Range Weighted Average Remaining Life (Years) Outstanding March 31, 2018 - $ - - Granted 3,050,000 $ 0.08 - .10 13.07 Cancelled/Expired - - - Exercised - - - Outstanding and exercisable March 31, 2019 3,050,000 $ 0.08 - .10 13.07 |